Education
About Us
Working with TipRanks
Follow Us
L. Becker Hewes Insider Profile
4 Followers
L. Becker Hewes, CMO at Blueprint Medicines, holds 264.63K shares in Galecto (Ticker: GLTO), holds 0.00 shares in Blueprint Medicines (Ticker: BPMC).
Profitable Transactions
4 out of 6 Profitable Transactions
Average Return
-18.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of L. Becker Hewes's holdings
Insider Roles
Chief Medical Officer
Roles that L. Becker Hewes holds in companies
Most Profitable Insider Trade
Stock:
Blueprint Medicines
(BPMC)
(BPMC)
Rating:Informative Sell
Date:Sep 17, 2021 - Sep 17, 2022
Return:+34.60%
The most profitable trade made by L. Becker Hewes
L. Becker Hewes's Trading History
Blueprint Medicines
Jul 21, 2025
―
Uninformative Buy
―
$0.00
Galecto
Jan 07, 2026
Chief Medical Officer
Uninformative Buy
―
$7.50M
List of latest transactions for each holding click on a transaction to see L. Becker Hewes's performance on stock
You May Also Like
L. Becker Hewes insider profile FAQ
What is the percentage of profitable transactions made by L. Becker Hewes?
The percentage of profitable transactions made by L. Becker Hewes is 67%.
What is the average return per transaction made by L. Becker Hewes?
The average return per transaction made by L. Becker Hewes is -18.70%.
What stocks does L. Becker Hewes hold?
L. Becker Hewes holds: BPMC, GLTO stocks.
What was L. Becker Hewes’s latest transaction?
L. Becker Hewes latest transaction was an Uninformative Buy of ―.
What was L. Becker Hewes's most profitable transaction?
L. Becker Hewes’s most profitable transaction was an Informative Sell of BPMC stock on September 17, 2021. The return on the trade was 34.60%.
What is L. Becker Hewes's role in Blueprint Medicines?
L. Becker Hewes's role in Blueprint Medicines is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.